5,752
Participants
Start Date
February 16, 2006
Primary Completion Date
January 29, 2014
Study Completion Date
January 29, 2014
Cervarix
Subjects were planned to receive three doses of the study vaccine administered intramuscularly according to a 0, 1, 6 month vaccination schedule.
Placebo control
Subjects were planned to receive three doses of the control vaccine administered intramuscularly according to a 0, 1, 6 month vaccination schedule.
GSK Investigational Site, Taft Avenue, Manila
GSK Investigational Site, Parkville
GSK Investigational Site, Bangkok
GSK Investigational Site, Bangkok
GSK Investigational Site, Syracuse
GSK Investigational Site, Wexford
GSK Investigational Site, Carnegie
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Erie
GSK Investigational Site, Erie
GSK Investigational Site, Philadelphia
GSK Investigational Site, Chapel Hill
GSK Investigational Site, New Bern
GSK Investigational Site, Augusta
GSK Investigational Site, Coral Gables
GSK Investigational Site, Miami
GSK Investigational Site, Bardstown
GSK Investigational Site, Louisville
GSK Investigational Site, Cleveland
GSK Investigational Site, Akron
GSK Investigational Site, Iowa City
GSK Investigational Site, La Crosse
GSK Investigational Site, Chaska
GSK Investigational Site, Cuenavaca
GSK Investigational Site, Wichita
GSK Investigational Site, Omaha
GSK Investigational Site, Tulsa
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Austin
GSK Investigational Site, Aurora
GSK Investigational Site, Golden
GSK Investigational Site, South Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Albuquerque
GSK Investigational Site, Fountain Valley
GSK Investigational Site, Portland
GSK Investigational Site, Wenatchee
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Singapore
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Singapore
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Lebanon
GSK Investigational Site, Perth
GSK Investigational Site, Jojutla / Morelos
GSK Investigational Site, Lima
GSK Investigational Site, Laguna
GSK Investigational Site, San Pablo
GSK Investigational Site, Edmonton
GSK Investigational Site, Vancouver
GSK Investigational Site, Halifax
GSK Investigational Site, Truro
GSK Investigational Site, Waterloo
GSK Investigational Site, Québec
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Amsterdam
GSK Investigational Site, Delft
GSK Investigational Site, Rotterdam
GSK Investigational Site, Almada
GSK Investigational Site, Coimbra
GSK Investigational Site, Lisbon
GSK Investigational Site, Porto
GSK Investigational Site, Setúbal
GSK Investigational Site, Moscow
GSK Investigational Site, Northwood
GSK Investigational Site, Aberdeen
GSK Investigational Site, Cardiff
GSK Investigational Site, Gateshead
GSK Investigational Site, London
GSK Investigational Site, Manchester
Lead Sponsor
GlaxoSmithKline
INDUSTRY